Filing Details

Accession Number:
0001209191-23-028533
Form Type:
4
Zero Holdings:
No
Publication Time:
2023-05-10 17:47:37
Reporting Period:
2023-05-08
Accepted Time:
2023-05-10 17:47:37
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1637715 Reneo Pharmaceuticals Inc. RPHM Pharmaceutical Preparations (2834) 472309515
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1780235 Niall O'donnell C/O Reneo Pharmaceuticals, Inc.
18575 Jamboree Road, Suite 275-S
Irvine CA 92612
Yes No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2023-05-08 125,000 $8.00 2,188,713 No 4 P Indirect By RiverVest Venture Fund IV, L.P.
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Indirect By RiverVest Venture Fund IV, L.P.
Footnotes
  1. The shares were purchased in the Issuer's public offering.
  2. The shares held by RiverVest Venture Fund IV, L.P. ("RiverVest Fund IV") are indirectly held by RiverVest Venture Partners IV, L.P., its general partner ("RiverVest Partners IV"). RiverVest Venture Partners IV, LLC is the general partner of RiverVest Partners IV. The individual managers of RiverVest Ventures Partners IV, LLC are Jay Schmelter, John P. McKearn, Ph.D. and the Reporting Person. RiverVest Partners IV, RiverVest Venture Partners IV, LLC and each of the individual managers (including the Reporting Person) share voting and dispositive power with regard to the Company's securities directly held by RiverVest Fund IV.